The Charles Institute

Launched in June 2008 with a total investment of €16.33 million, The Charles Institute is the first academic institute devoted to dermatology in Ireland. The Institute’s vision is to become a world leader in dermatology research and training, which will lead to improved patient care through the discovery of new treatments and therapies.

Academic Research

THE CDSCHC & THE CHARLES INSTITUTE

“To build on the legacy of The City of Dublin Skin and Cancer Hospital by creating a centre of excellence of international repute.”

In 2008, The City of Dublin Skin and Cancer Hospital Charity in partnership with University College Dublin founded the Charles Institute, named in honour of Andrew Charles FRCSI, the founder of the City of Dublin Skin and Cancer Hospital (known as Hume Street Hospital) and his son Havelock Charles who worked as a consultant dermatologist in the hospital throughout his life.

Honouring the vision and commitment of the founding fathers and all of the dedicated staff who worked in the hospital from its foundation in 1911 to its closure in 2006, the City of Dublin Skin and Cancer Hospital Charity has become the major donor to the Charles Institute, contributing a portion of the proceeds from the sale of the Hume Street Hospital site towards the establishment of the Institute. The objectives of the Institute as envisioned by the Charity are outlined below.

  • I

    To build on the legacy of The City of Dublin Skin and Cancer Hospital by creating a centre of excellence of international repute.

  • II

    To initiate and conduct research programs for the advancement of the understanding and treatment of dermatological disease in close association with the Conway Institute and Health Sciences Centre.

  • III

    To provide the facilities necessary for the future training of all healthcare professionals dedicated to curing skin disease.

  • IV

    To structure a National programme that supports Irelands community of dermatologists through continued medical education and patient advocacy.

  • V

    To develop the translational model of bench-to-bedside research through close collaboration between the existing dermatological services in St. Vincent’s University Hospital and the Charles Institute.

  • VI

    To ensure ultimately that these objectives will result in the betterment of dermatological treatment for the many thousands of patients in Ireland who suffer from skin disease and its many manifestations.